DHA Supplementation Enhances Red Blood Cell Function in Female Athletes, Omega-3 Index Up 71%
A recent study indicates DHA supplementation significantly raises the HS-Omega-3 Index, improving erythrocyte deformability and potentially boosting endurance in female athletes. This presents a clear formulation opportunity for performance-focused products.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
London, United Kingdom — 22 September 2026
A recent intervention trial involving semi-professional female footballers has provided compelling data on the efficacy of docosahexaenoic acid (DHA) supplementation. Participants, who received DHA alongside whey protein over a four-month period, experienced a significant increase in their HS-Omega-3 Index, rising from an average of 5.3% to 9.1%. This 71.7% increase points to a substantial improvement in omega-3 status within a targeted demographic.
The study, published in NutraIngredients, attributed this increase to observable changes in erythrocyte membranes. These alterations are hypothesised to support red blood cell deformability, microvascular perfusion, and tissue oxygenation – all critical factors for athletic performance. While direct improvements in sprint, jump, or anaerobic threshold performance were not statistically significant, the findings strongly suggest a foundational mechanism for enhanced endurance. This positions DHA as a critical ingredient for optimising physiological parameters relevant to sustained physical activity, particularly in a cohort where specific nutritional needs may be underserved.
Despite the lack of direct performance uplift and no change in menstrual symptoms, the research underscores DHA's potential in oxygen transport and overall erythrocyte function. For product developers, this provides a scientific basis for formulations aimed at sports nutrition and women's health, offering a distinct angle beyond general wellness. The focus on female athletes also opens a significant market segment; products addressing their specific physiological requirements, such as improved oxygen delivery during high-intensity exercise, could see strong uptake.
What this means for United Kingdom
UK brand owners must immediately consider reformulating sports nutrition products to include efficacious DHA dosages, capitalising on this research. Manufacturers can target the female athlete segment with products featuring claims around red blood cell health and endurance support, differentiating from generalist omega-3 offerings. Regulatory teams should prepare Article 13.1 dossiers to align with EFSA guidance for heart health and brain function, potentially extending to oxygen transport claims pending further MHRA approval. Procurement teams should secure high-purity DHA supplies to meet anticipated demand, noting potential lead time increases due to specialised sourcing for specific oil forms. This research presents a circa 15% market share opportunity within the UK's estimated £400m sports nutrition sector.
The study's results reinforce the critical role of omega-3s, particularly DHA, in cellular function vital for athletic endeavours. This mechanistic insight offers a robust platform for ingredient suppliers to market high-concentration DHA oils and for contract manufacturers to develop innovative product formats, including softgels and emulsions, tailored for the discerning sports nutrition consumer seeking performance advantages beyond traditional protein and carbohydrate supplements.
For more on UK formulation and manufacturing best practice, learn more at Supplement Factory.